AAIC 2026 A comparative effectiveness analysis of second-line diabetes medications in realworld registry (Danish registry) comparing GLP-1 RAs to other agents found a protective effect of GLP-1 RAs vs certain other second-line drugs over 5 years, though not against all comparators
A generic liraglutide option for Victoza for treatment of type 2 diabetes was FDA-approved on December 23, 2024
Animal studies indicate dose-dependent effects, with toxic doses possibly affecting copper metabolism or interacting with embryonic development in hypersensitive models, warranting caution during pregnancy
As a trusted medical weight loss clinic in Hamilton, Alabama, accepting insurance, Klinic dedicates itself to making weight loss achievable and affordable for all
The agency said the use of Orange B has been abandoned by the food industry, and therefore, the regulation is outdated and unnecessary